Create a healthier society by investing in much-needed innovations at the interface of nutrition, biology, and technology.
Why Invest Now?
Powerful trends are converging to create a transformative investment opportunity.
$1.1T
Annual U.S. healthcare costs stem from diet-related diseases. Only 6.8% of American adults have optimal metabolic health.
Rockefeller Foundation, 2021
20M+
Americans taking GLP-1 drugs, creating massive new demand for foods that support metabolic health and personalized nutrition.
American Diabetes Association, 2024
AI + Bio
Advances in AI and molecular food science now enable faster, lower-cost development of evidence-based health solutions.
FHA invests in early-stage companies that apply science, data, and technology to improve metabolic health, performance, and healthy longevity.
We focus on commercially scalable innovations that deliver measurable human benefit and strong financial return.
Next-gen bioactives, fermented ingredients, and AI-assisted formulation platforms turning molecular science into scalable foods.
Biosensors, data platforms, and "food-as-medicine" programs integrating nutrition into healthcare and daily decision-making.
Leveraging UC Davis and Sacramento's strengths to build a globally connected ecosystem of investors and researchers.
Seeking Catalytic Capital?
FHA provides swift capital that accelerates innovation. We invest in early-stage companies applying science and technology to improve metabolic health and performance.
We utilize a rigorous due diligence process via our monthly Screening Committee. To receive information on our intake process, please contact us.
Email info@fhangels.orgWe are seeking 50 passionate individuals to join us as charter members. Gain access to curated deal flow, help build our network, and drive the future of health.
Accredited Investor
$1M+ net worth or $200k+ income
Annual Fee
$2,500 (Individual) / $20,000 (Corporate)
Active Participation
Attend events, help screen, or source deals
By invitation only. Applications reviewed monthly.
A leadership team bringing diverse expertise in investment, venture development, and breakthrough science.